Summary of opinion: Supemtek Tetra (previously Supemtek), 27/02/2025 Positive
Summary of opinion: Supemtek Tetra (previously Supemtek), 27/02/2025 Positive
Summary of opinion: Supemtek Tetra (previously Supemtek), 27/02/2025 Positive
Summary of opinion: Prevymis, 27/02/2025 Positive
Summary of opinion: Fabhalta, 27/02/2025 Positive
First topical gene therapy treatment for dystrophic epidermolysis bullosa
Summary of opinion: Imfinzi, 27/02/2025 Positive
Summary of opinion: Kaftrio, 27/02/2025 Positive
Combination of cystic fibrosis medicines to treat patients with rare mutations
Summary of opinion: Columvi, 27/02/2025 Positive
List of centrally authorised products with safety-related changes to the product information
Procedural advice on CHMP/CAT/PRAC Rapporteur/Co-Rapporteur appointment principles, objective criteria and methodology in accordance with Article 62 (1) of Regulation (EC) No 726/2004